Dan Mulreany
Corporate Officer/Principal at APOGEE THERAPEUTICS, INC.
Network origin in Dan Mulreany first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 25 | |
| Public Company | Biotechnology | 19 | |
The Wharton Health Care Alumni Association
1
| Non-Profit Organization | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dan Mulreany via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | Multi-Line Insurance | Chief Investment Officer Chief Investment Officer | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Executive Officer Chairman Corporate Officer/Principal | |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
Truist Securities, Inc.
 Truist Securities, Inc. Investment Banks/BrokersFinance Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| INVITAE CORPORATION | Medical/Nursing Services | Chairman Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Hamilton College (New York) | College/University | Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Texas A&M University | College/University | Graduate Degree Graduate Degree | |
| University of Vermont | College/University | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
The Business Council
 The Business Council Miscellaneous Commercial ServicesCommercial Services The Business Council operates as an organization of business leaders. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Chief Administrative Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| EIDOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Investor Relations Contact Chief Executive Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Viridian LLC
 Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Founder Founder | |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| INVIVYD, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Doctorate Degree |
Statistics
International
| United States | 45 |
| Canada | 2 |
| France | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 15 |
| Finance | 10 |
| Commercial Services | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 149 |
| Corporate Officer/Principal | 101 |
| Independent Dir/Board Member | 55 |
| Undergraduate Degree | 43 |
| Chairman | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Brenton Saunders | 38 |
| Fred Hassan | 29 |
| Eric Aguiar | 29 |
| Jane Henderson | 24 |
| Ronald Daniels | 17 |
| Christine Siu | 15 |
| William Jones | 14 |
| Michael Henderson | 14 |
| Jennifer Cook | 13 |
| R. Session | 13 |
| Jennifer Fox | 13 |
| Douglas Dachille | 12 |
| Brian Stolz | 12 |
| Peter Harwin | 11 |
| Mark Mckenna | 11 |
- Stock Market
- Insiders
- Dan Mulreany
- Company connections
